Page 828 - ACCCN's Critical Care Nursing

I N D E X 805

living donor 787 invasive see invasive mechanical ventilation MOV see minimal occluding volume
liver transplantation 523 non-invasive see non-invasive ventilation MPM see mortality probability models
living will 787 physiologic indications for 388t MRC see Medical Research Council scale
LN liasion nurse pregnancy and 731–732 MRI see magnetic resonance imaging
lobar collapse 345 principles of 388–389 MRO see multi-resistant organisms
lochia, postpartum patient and 736 compliance 388 MRSA see methicillin-resistant Staphylococcus
locked-in syndrome 433 elastance 388 aureus
lower airway branches 327f equation of motion 388, 388t mucosal hypoperfusion 507
lower airway disease, in children 691–693 resistance 388–389 consequences of 507–508, 508t
asthma 692–693, 692t medical emergency team (MET) calling multifocal atrial tachycardia 255, 255f
bronchiolitis 691 criteria 51, 51t multiorgan donor 750–754, 787
lower respiratory tract, anatomy of 326 medical futility 86–87 potential 787
low-flow nasal cannulae 382 medical outcomes study see SF-36 multiple organ dysfunction syndrome
lung transplantation 369–374 Medical Research Council (MRC) scale 58 (MODS) 552t, 569–572, 787
allograft dysfunction and 371–373 medulla oblongata 421t–422t, 423 ACE-inhibitor therapy in, research
bilateral sequential 370 melatonin, sleep and 149 vignette 573b–574b
clinical manifestations of 370–374 MELD see model for end-stage liver disease case study 572b–573b
haemodynamic instability 373–374 scoring system nursing practice in 571–572
long-term sequelae 374 memories 63 effective shock resuscitation 571
pain 373 meningitis 464–465 infection treatment 571–572
psychosocial care 374 in children 697–698, 697t organ support 572
renal and gut dysfunction 374 classification of 466t secondary insult exclusion 572
respiratory dysfunction 371–373 collaborative care 465 pathophysiology of 563–564, 563f
forms of 370, 370t complications of 465 progression of 566f
indications for 369 CSF profiles in 465t scoring systems for 570
low cardiac output after 371t mental health systemic response 564–567
single 370 pregnancy and 731 compensatory mechanisms 567
lungs 326–328, 327f triage assessment presentations 585, 585t endocrine system 566–567
LVEDV see left ventricular end-diastolic volume mentorship 10–11 immune system 565
LVF see left ventricular failure MET see medical emergency team infection 565
LVSWI see left ventricular stroke work index metabolism inflammation 565
lysis 787 derangement, liver failure and 519 oedema 565
gastrointestinal alterations to 508 procoagulation 565–566
TPN and 513, 514t
stress response actions 566t
M metabolites 787 tissue factor pathway 564f
MAAS see Motor Activity Assessment Scale methicillin-resistant Staphylococcus aureus see also organ dysfunction
macroglia 417, 419t (MRSA) 121 multiple patient triage 588–589
magnetic resonance imaging (MRI) MEWS see modified early warning score multi-resistant organisms (MRO) 121
of brain injury 436 MI see myocardial infarction murmurs 191–192, 192t
functional 436 microdialysis 439 Murray Valley encephalitis (MVE) 466
cardiovascular system and 209–210 microglia 417, 419t muscles
DSC, of cerebral perfusion 436 microshock protection 275 cardiac, electron micrograph of 181–182,
respiratory system and 347 midbrain 421t–422t, 423 182f
malignancy, post heart transplantation 318 MIDCABG see minimally invasive direct waisting 58
malnutrition, consequences of 509 coronary artery bypass grafting limiting 59b
management role, leadership and 29 mild brain injury 457 musculoskeletal system
manual muscle testing (MMT) 58 minimal leak test (MLT) 386 assessment 111, 111t
Māori creation stories 166 minimal occluding volume (MOV) 386 of children 683–684
Māori patients and families minimally invasive direct coronary artery bypass MV see minute volume
case study 174b grafting (MIDCABG) 293–294 MVE see Murray Valley encephalitis
working with 166–168, 167t minute volume (MV) 331 myasthenia gravis 469–470
margination 787 mitral valve disease 293 aetiology 469
massage therapy, for post cardiac surgery, MLT see minimal leak test clinical manifestations of 469
research vignette 321b MMT see manual muscle testing nursing practice 469–470
massive blood transfusion, hypovolaemic shock mobilisation pathophysiology of 469
and in ICU 66, 67t myelin sheath 415
indicators for 544f walking and 66 myocardial infarction (MI) 216–227
physiological derangements of 543f positioning patient and 111–115 acute 216
maternal-fetal interface 715–716 of trauma patient 626–627, 628t angina management 221, 222f
maternal-infant attachment, promotion of 738 Mobitz type II 260–261 assessment and 217–221, 217t
maternal-placental interface 715, 715f model for end-stage liver disease (MELD) biochemical markers for 218–219
McGill short pain questionnaire 143t scoring system 522 cardiac rehabilitation 226–227
MCS see mechanical circulatory support models of care 157–161 chest radiography for 220–221
mechanical circulatory support (MCS) 308, communication 158–161 clinical features of 217
310f, 787 family-centred see family-centred care complications of 227
mechanical ventilation 388–389 modified early warning score (MEWS) 51, 51t arrhythmias 227
case study 406b MODS see multiple organ dysfunction syndrome cardiogenic shock 227
children and 693–695 monophasic 787 pericarditis 227
ECMO 694–695 morphine sulfate 144, 145t structural defects 227
HFOV 694 mortality probability models (MPM) 570 coronary angiography for 219–220
modes of 694–695 Motor Activity Assessment Scale (MAAS) 141t diagnostic features of 217–221
non-invasive 694 motor control 430–431 ECG evolution pattern 218, 219f–220f
pressure 694 motor function alterations 446–447 ECG examination 218
volume 694 motor tone 434 emotional response and 226
circuits 389 mouth care 109–110 exercise test for 220
humidification see humidification mouthwashes 109–110 left heart catheterisation for 219–220